AstraZeneca Pops Ahead of Covid-19 Vaccine Data Report Due July 20

Shares in AstraZeneca (AZN) spiked almost 5% in after-market trading amid a report that early-stage human trial data on the drugmaker’s coronavirus vaccine candidate will be disclosed on July 20.


The stock rose to $60.60 in...